Thromb Haemost
DOI: 10.1055/s-0044-1781425
Stroke, Systemic or Venous Thromboembolism

No Genetic Causality between Tobacco Smoking and Venous Thromboembolism: A Two-Sample Mendelian Randomization Study

Hong-Cheng Du
1   Graduate School of Guangxi University of Chinese Medicine, Nanning, China
,
Yun-Fei Zheng
1   Graduate School of Guangxi University of Chinese Medicine, Nanning, China
,
Meng-Qi Shen
1   Graduate School of Guangxi University of Chinese Medicine, Nanning, China
,
Bai-Yang Deng
2   Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, China
› Author Affiliations


Abstract

Background Given the current debate in clinical research about the relationship between tobacco smoking and the risk of venous thromboembolism (VTE), a Mendelian randomization (MR) study was conducted aimed at elucidating the causal associations of current and past tobacco smoking with the risk of VTE, from the perspective of genetics.

Methods Two-sample univariate and multivariable MR analyses were designed, using summary-level data from large genome-wide association studies involving European individuals. Causality was primarily assessed using multiplicative fixed-effects or random-effects model and inverse variance weighting, supplemented by MR–Egger regression, MR-PRESSO, Cochran's Q test, and leave-one-out for sensitivity analysis to test the reliability of the results.

Results In the univariate MR analysis, no significant causal effects were found between current tobacco smoking and the risk of VTE, deep vein thrombosis (DVT), and pulmonary embolism (PE). Similarly, no significant causal effects were found between past smoking and VTE, DVT, and PE. As for the multivariable MR analysis, results were consistent with univariate MR analysis, with no significant causal effect of either current or past tobacco smoking on the risk of VTE, DVT, and PE.

Conclusion Evidence from both univariate and multivariable MR analyses demonstrated no significant causal relationships between current and past tobacco smoking and VTE, DVT, and PE. This contradicts positive correlations reported in some previous observational studies, which may be explained by other confounding factors. This provided genetic evidence for the conclusion reported in other observational studies that smoking did not affect VTE risk.

Authors' Contribution

B.-Y.D. contributed to guiding the research process. H.-C.D. and Y.-F.Z. contributed to conceptualization and methodology. H.-C.D. contributed to study design, statistical analysis, and writing the original draft. All authors contributed to data collection, reviewing, editing and approves the final manuscript.




Publication History

Received: 18 October 2023

Accepted: 29 January 2024

Article published online:
22 February 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Khan F, Tritschler T, Kahn SR, Rodger MA. Venous thromboembolism. Lancet 2021; 398 (10294): 64-77
  • 2 Beckman MG, Hooper WC, Critchley SE, Ortel TL. Venous thromboembolism: a public health concern. Am J Prev Med 2010; 38 (4, Suppl) S495-S501
  • 3 Essien EO, Rali P, Mathai SC. Pulmonary embolism. Med Clin North Am 2019; 103 (03) 549-564
  • 4 Huisman MV, Barco S, Cannegieter SC. et al. Pulmonary embolism. Nat Rev Dis Primers 2018; 4 (01) 18028
  • 5 Duffett L. Deep venous thrombosis. Ann Intern Med 2022; 175 (09) ITC129-ITC144
  • 6 Wendelboe AM, McCumber M, Hylek EM, Buller H, Weitz JI, Raskob G. ISTH Steering Committee for World Thrombosis Day. Global public awareness of venous thromboembolism. J Thromb Haemost 2015; 13 (08) 1365-1371
  • 7 Holst AG, Jensen G, Prescott E. Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study. Circulation 2010; 121 (17) 1896-1903
  • 8 Wattanakit K, Lutsey PL, Bell EJ. et al. Association between cardiovascular disease risk factors and occurrence of venous thromboembolism. A time-dependent analysis. Thromb Haemost 2012; 108 (03) 508-515
  • 9 Wang T, Guo J, Long Y, Yin Y, Hou Z. Risk factors for preoperative deep venous thrombosis in hip fracture patients: a meta-analysis. J Orthop Traumatol 2022; 23 (01) 19
  • 10 Gregson J, Kaptoge S, Bolton T. et al; Emerging Risk Factors Collaboration. Cardiovascular risk factors associated with venous thromboembolism. JAMA Cardiol 2019; 4 (02) 163-173
  • 11 Severinsen MT, Kristensen SR, Johnsen SP, Dethlefsen C, Tjønneland A, Overvad K. Smoking and venous thromboembolism: a Danish follow-up study. J Thromb Haemost 2009; 7 (08) 1297-1303
  • 12 Musil D, Kaletová M, Herman J. Venous thromboembolism - prevalence and risk factors in chronic venous disease patients. Phlebology 2017; 32 (02) 135-140
  • 13 Carruzzo P, Méan M, Limacher A, Aujesky D, Cornuz J, Clair C. Association between smoking and recurrence of venous thromboembolism and bleeding in elderly patients with past acute venous thromboembolism. Thromb Res 2016; 138: 74-79
  • 14 Wang H, Rosendaal FR, Cushman M, van Hylckama Vlieg A. Association between cardiovascular risk factors and venous thromboembolism in the elderly. Res Pract Thromb Haemost 2022; 6 (02) e12671
  • 15 Andrei MC, Andercou A. Is there a link between atherothrombosis and deep venous thrombosis?. Maedica (Buchar) 2014; 9 (01) 94-97
  • 16 Pastori D, Cormaci VM, Marucci S. et al. A comprehensive review of risk factors for venous thromboembolism: from epidemiology to pathophysiology. Int J Mol Sci 2023; 24 (04) 3169
  • 17 Deflandre E, Degey S, Opsomer N, Brichant JF, Joris J. Obstructive sleep apnea and smoking as a risk factor for venous thromboembolism events: review of the literature on the common pathophysiological mechanisms. Obes Surg 2016; 26 (03) 640-648
  • 18 Siasos G, Tsigkou V, Kokkou E. et al. Smoking and atherosclerosis: mechanisms of disease and new therapeutic approaches. Curr Med Chem 2014; 21 (34) 3936-3948
  • 19 Previtali E, Bucciarelli P, Passamonti SM, Martinelli I. Risk factors for venous and arterial thrombosis. Blood Transfus 2011; 9 (02) 120-138
  • 20 Enga KF, Braekkan SK, Hansen-Krone IJ, le Cessie S, Rosendaal FR, Hansen JB. Cigarette smoking and the risk of venous thromboembolism: the Tromsø study. J Thromb Haemost 2012; 10 (10) 2068-2074
  • 21 MacDonald CJ, Madika AL, Lajous M, Canonico M, Fournier A, Boutron-Ruault MC. Association between cardiovascular risk-factors and venous thromboembolism in a large longitudinal study of French women. Thromb J 2021; 19 (01) 58
  • 22 Skrivankova VW, Richmond RC, Woolf BAR. et al. Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement. JAMA 2021; 326 (16) 1614-1621
  • 23 Boyko EJ. Observational research–opportunities and limitations. J Diabetes Complications 2013; 27 (06) 642-648
  • 24 Yadav K, Lewis RJ. Immortal time bias in observational studies. JAMA 2021; 325 (07) 686-687
  • 25 Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet 2014; 23 (R1): R89-R98
  • 26 Sekula P, Del Greco M F, Pattaro C, Köttgen A. Mendelian randomization as an approach to assess causality using observational data. J Am Soc Nephrol 2016; 27 (11) 3253-3265
  • 27 Holmes MV, Ala-Korpela M, Smith GD. Mendelian randomization in cardiometabolic disease: challenges in evaluating causality. Nat Rev Cardiol 2017; 14 (10) 577-590
  • 28 IEU OpenGWAS project. GWAS summary data. Accessed October 4, 2023 at: https://gwas.mrcieu.ac.uk/
  • 29 Sudlow C, Gallacher J, Allen N. et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med 2015; 12 (03) e1001779
  • 30 Kurki MI, Karjalainen J, Palta P. et al; FinnGen. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 2023; 613 (7944) 508-518
  • 31 Machiela MJ, Chanock SJ. LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants. Bioinformatics 2015; 31 (21) 3555-3557
  • 32 Burgess S, Dudbridge F, Thompson SG. Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods. Stat Med 2016; 35 (11) 1880-1906
  • 33 PhenoScanner. Accessed October 9, 2023 at: http://www.phenoscanner.medschl.cam.ac.uk/
  • 34 O'Toole RV, Stein DM, O'Hara NN. et al; Major Extremity Trauma Research Consortium (METRC). Aspirin or low-molecular-weight heparin for thromboprophylaxis after a fracture. N Engl J Med 2023; 388 (03) 203-213
  • 35 Nazarzadeh M, Bidel Z, Mohseni H. et al; INVENT Consortium. Blood pressure and risk of venous thromboembolism: a cohort analysis of 5.5 million UK adults and Mendelian randomization studies. Cardiovasc Res 2023; 119 (03) 835-842
  • 36 Xu WJ, Wang S, Yuan P, Wang L, Huang JX, Jiang R. Arterial and venous thromboembolism risk associated with blood eosinophils: a systematic review and meta-analysis. Animal Model Exp Med 2022; 5 (05) 470-481
  • 37 Bettiol A, Galora S, Argento FR. et al. Erythrocyte oxidative stress and thrombosis. Expert Rev Mol Med 2022; 24: e31
  • 38 Oğuz S. Relationship between first values of red cell distribution width, mean platelet volume, platelet distribution width, and hospital mortality in acute deep venous thrombosis. J Coll Physicians Surg Pak 2021; 30 (04) 379-382
  • 39 Aleman MM, Walton BL, Byrnes JR, Wolberg AS. Fibrinogen and red blood cells in venous thrombosis. Thromb Res 2014; 133 (0 1, Suppl 1): S38-S40
  • 40 Burgess S, Thompson SG. CRP CHD Genetics Collaboration. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol 2011; 40 (03) 755-764
  • 41 Pierce BL, Ahsan H, Vanderweele TJ. Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. Int J Epidemiol 2011; 40 (03) 740-752
  • 42 Sanderson E, Spiller W, Bowden J. Testing and correcting for weak and pleiotropic instruments in two-sample multivariable Mendelian randomization. Stat Med 2021; 40 (25) 5434-5452
  • 43 Burgess S, Bowden J, Fall T, Ingelsson E, Thompson SG. Sensitivity analyses for robust causal inference from Mendelian randomization analyses with multiple genetic variants. Epidemiology 2017; 28 (01) 30-42
  • 44 Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet 2018; 50 (05) 693-698
  • 45 Bowden J, Holmes MV. Meta-analysis and Mendelian randomization: a review. Res Synth Methods 2019; 10 (04) 486-496
  • 46 Blondon M, Wiggins KL, McKnight B. et al. The association of smoking with venous thrombosis in women. A population-based, case-control study. Thromb Haemost 2013; 109 (05) 891-896
  • 47 Messerlian C, Basso O. Cohort studies in the context of obstetric and gynecologic research: a methodologic overview. Acta Obstet Gynecol Scand 2018; 97 (04) 371-379
  • 48 Van Heijl I, Schweitzer VA, Van Der Linden PD, Bonten MJM, Van Werkhoven CH. Impact of antimicrobial de-escalation on mortality: a literature review of study methodology and recommendations for observational studies. Expert Rev Anti Infect Ther 2020; 18 (05) 405-413
  • 49 Cheng YJ, Liu ZH, Yao FJ. et al. Current and former smoking and risk for venous thromboembolism: a systematic review and meta-analysis. PLoS Med 2013; 10 (09) e1001515
  • 50 Braekkan SK, Mathiesen EB, Njølstad I, Wilsgaard T, Størmer J, Hansen JB. Family history of myocardial infarction is an independent risk factor for venous thromboembolism: the Tromsø study. J Thromb Haemost 2008; 6 (11) 1851-1857
  • 51 Brækkan SK, Hald EM, Mathiesen EB. et al. Competing risk of atherosclerotic risk factors for arterial and venous thrombosis in a general population: the Tromso study. Arterioscler Thromb Vasc Biol 2012; 32 (02) 487-491
  • 52 Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW. Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation 2008; 117 (01) 93-102
  • 53 Mahmoodi BK, Cushman M, Anne Næss I. et al. Association of traditional cardiovascular risk factors with venous thromboembolism: an individual participant data meta-analysis of prospective studies. Circulation 2017; 135 (01) 7-16